この画面を閉じる

文献元のページへ

TaKaRa DEXPAT™

使用文献

DEXPAT(製品コード 9091)Citations

  • J Clin Microbiol. 2006 ;44(2):612-3.
    Chedore P, et al.
    False-positive amplified Mycobacterium tuberculosis direct test results for samples containing Mycobacterium leprae.


  • Clin Cancer Res. 2006 ;12(1):43-8.
    Asano H, et al.
    Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay.


  • Jpn J Clin Oncol. 2006 ;36(1):17-24.
    Ryu MH, et al.
    Patterns of progression in gastrointestinal stromal tumor treated with imatinib mesylate.


  • J Clin Microbiol. 2006 ;44(5):1859-62.
    Umeyama T, et al.
    Novel approach to designing primers for identification and distinction of the human pathogenic fungi Coccidioides immitis and Coccidioides posadasii by PCR amplification.


  • Clin Cancer Res. 2006 ;12(13):3915-21.
    Kimura H, et al.
    Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer.


  • Jpn J Clin Oncol. 2006 ;36(8):523-6.
    Chou WC, et al.
    Different responses to gefitinib in lung adenocarcinoma coexpressing mutant- and wild-type epidermal growth factor receptor genes.


  • Clin Cancer Res. 2006 ;12(20 Pt 1):6116-24.
    Yoshino T, et al.
    Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy.


  • Carcinogenesis. 2005 ;26(1):229-238.
    Tanaka T, et al.
    Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess {beta}-catenin gene mutations and increases immunoreactivity for {beta}-catenin, cyclooxygenase-2 and inducible nitric oxide synthase.


  • Cancer Res. 2005 ;65(5):1897-903.
    Basciani S, et al.
    Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.


  • J Clin Pathol. 2005 ;58(3):334.
    Paterson PJ, et al.
    Molecular confirmation of invasive infection caused by Chaetomium globosum.


  • Vet Pathol. 2005 ;42(2):176-83.
    Toyoda T, et al.
    Multiple perineuriomas in chicken (Gallus gallus domesticus).


  • Clin Cancer Res. 2005 ;11(3):1167-73.
    Tokumo M, et al.
    The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers.


  • Ann Oncol. 2005 ;16(8):1334-42.
    Zhang XT, et al.
    The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer.


  • Clin Cancer Res. 2005 ;11(11):4067-73.
    de Jong KP, et al.
    P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.


  • Clin Cancer Res. 2004 ;10(24):8195-203.
    Huang SF, et al.
    High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan.


  • Carcinogenesis. 2004 ;25(10):1967-72.
    Kawamori T, et al.
    Carcinogenicity of aminophenylnorharman, a possible novel endogenous mutagen, formed from norharman and aniline, in F344 rats.


参考文献

TaKaRa DEXPAT
1)Goelz, S. E. et al.(1985)BBRC, 130, No. 1, 118-126.
2)佐藤雄一ら(1990)病理と臨床 (別冊), 8, 432-453.

この画面を閉じる